Corrigendum to “Evaluation of Novel Stereotactic Cannula for Stem Cell Transplantation against Central Nervous System Disease”
Main Authors: | Masahito Kawabori, Aki Tanimori, Shinri Kitta, Hideo Shichinohe, Kiyohiro Houkin |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2021/9796010 |
Similar Items
-
Evaluation of Novel Stereotactic Cannula for Stem Cell Transplantation against Central Nervous System Disease
by: Masahito Kawabori, et al.
Published: (2020-01-01) -
Clinical Trials of Stem Cell Therapy for Cerebral Ischemic Stroke
by: Masahito Kawabori, et al.
Published: (2020-10-01) -
Clinical Trials of Stem Cell Treatment for Spinal Cord Injury
by: Kazuyoshi Yamazaki, et al.
Published: (2020-06-01) -
Research on advanced intervention using novel bone marrOW stem cell (RAINBOW): a study protocol for a phase I, open-label, uncontrolled, dose-response trial of autologous bone marrow stromal cell transplantation in patients with acute ischemic stroke
by: Hideo Shichinohe, et al.
Published: (2017-09-01) -
Review of past and present research on experimental models of moyamoya disease
by: Shuji Hamauchi, et al.
Published: (2015-01-01)